Search Results - "Silva, Patrícia M M"

Refine Results
  1. 1

    Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research by Pinto, Bárbara, Henriques, Ana C, Silva, Patrícia M A, Bousbaa, Hassan

    Published in Pharmaceutics (06-12-2020)
    “…Most cancer biologists still rely on conventional two-dimensional (2D) monolayer culture techniques to test in vitro anti-tumor drugs prior to in vivo testing…”
    Get full text
    Journal Article
  2. 2

    Robotic assisted gait as a tool for rehabilitation of individuals with spinal cord injury: a systematic review by Holanda, Ledycnarf J, Silva, Patrícia M M, Amorim, Thiago C, Lacerda, Matheus O, Simão, Camila R, Morya, Edgard

    “…Spinal cord injury (SCI) is characterized by a total or partial deficit of sensory and motor pathways. Impairments of this injury compromise muscle recruitment…”
    Get full text
    Journal Article
  3. 3

    BP-M345 as a Basis for the Discovery of New Diarylpentanoids with Promising Antimitotic Activity by Moreira, Joana, Silva, Patrícia M A, Castro, Eliseba, Saraiva, Lucília, Pinto, Madalena, Bousbaa, Hassan, Cidade, Honorina

    “…Recently, the diarylpentanoid ( ) has been identified as a potent in vitro growth inhibitor of cancer cells, with a GI value between 0.17 and 0.45 µM, showing…”
    Get full text
    Journal Article
  4. 4

    Antagonizing the spindle assembly checkpoint silencing enhances paclitaxel and Navitoclax-mediated apoptosis with distinct mechanistic by Henriques, Ana C., Silva, Patrícia M. A., Sarmento, Bruno, Bousbaa, Hassan

    Published in Scientific reports (18-02-2021)
    “…Antimitotic drugs arrest cells in mitosis through chronic activation of the spindle assembly checkpoint (SAC), leading to cell death. However, drug-treated…”
    Get full text
    Journal Article
  5. 5

    Second-Generation Antimitotics in Cancer Clinical Trials by Novais, Pedro, Silva, Patrícia M. A., Amorim, Isabel, Bousbaa, Hassan

    Published in Pharmaceutics (02-07-2021)
    “…Mitosis represents a promising target to block cancer cell proliferation. Classical antimitotics, mainly microtubule-targeting agents (MTAs), such as taxanes…”
    Get full text
    Journal Article
  6. 6

    Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance by Cunha, Andrea, Silva, Patrícia M. A, Sarmento, Bruno, Queirós, Odília

    Published in Pharmaceutics (01-11-2023)
    “…The “Warburg effect” consists of a metabolic shift in energy production from oxidative phosphorylation to glycolysis. The continuous activation of glycolysis…”
    Get full text
    Journal Article
  7. 7

    Evaluation of Antitumor Activity of Xanthones Conjugated with Amino Acids by Barbosa, Flávia, Araújo, Joana, Gonçalves, Virgínia M F, Palmeira, Andreia, Cunha, Andrea, Silva, Patrícia M A, Fernandes, Carla, Pinto, Madalena, Bousbaa, Hassan, Queirós, Odília, Tiritan, Maria Elizabeth

    “…Cancer is a complex disease characterized by several alterations, which confer, to the cells, the capacity to proliferate uncontrollably and to resist cellular…”
    Get full text
    Journal Article
  8. 8

    Combination Therapy as a Promising Way to Fight Oral Cancer by Silva, João P N, Pinto, Bárbara, Monteiro, Luís, Silva, Patrícia M A, Bousbaa, Hassan

    Published in Pharmaceutics (01-06-2023)
    “…Oral cancer is a highly aggressive tumor with invasive properties that can lead to metastasis and high mortality rates. Conventional treatment strategies, such…”
    Get full text
    Journal Article
  9. 9

    Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer by Calheiros-Lobo, Mafalda, Silva, João P N, Pinto, Bárbara, Monteiro, Luís, Silva, Patrícia M A, Bousbaa, Hassan

    Published in Pharmaceutics (11-09-2024)
    “…Head and neck cancer (HNC), the sixth most common cancer worldwide, is increasing in incidence, with oral squamous cell carcinoma (OSCC) as the predominant…”
    Get full text
    Journal Article
  10. 10

    BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity by Novais, Pedro, Silva, Patrícia M A, Moreira, Joana, Palmeira, Andreia, Amorim, Isabel, Pinto, Madalena, Cidade, Honorina, Bousbaa, Hassan

    Published in Molecules (Basel, Switzerland) (25-11-2021)
    “…Previously, we reported the in vitro growth inhibitory effect of diarylpentanoid BP-M345 on human cancer cells. Nevertheless, at that time, the cellular…”
    Get full text
    Journal Article
  11. 11

    Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure-Activity Relationship Studies by Moreira, Joana, Silva, Patrícia M A, Barros, Matilde, Saraiva, Lucília, Pinto, Madalena, Bousbaa, Hassan, Cidade, Honorina

    Published in Pharmaceuticals (Basel, Switzerland) (01-06-2023)
    “…In this work, the design and synthesis of a new chalcone-trimethoxycinnamide hybrid ( ) based on the combination of subunits of two promising antiproliferative…”
    Get full text
    Journal Article
  12. 12

    Coupling Kinesin Spindle Protein and Aurora B Inhibition with Apoptosis Induction Enhances Oral Cancer Cell Killing by Silva, João P N, Pinto, Bárbara, Monteiro, Luís, Silva, Patrícia M A, Bousbaa, Hassan

    Published in Cancers (25-05-2024)
    “…Many proteins regulating mitosis have emerged as targets for cancer therapy, including the kinesin spindle protein (KSP) and Aurora kinase B (AurB). KSP is…”
    Get full text
    Journal Article
  13. 13

    Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction by Pinto, Bárbara, Silva, João P N, Silva, Patrícia M A, Barbosa, Daniel José, Sarmento, Bruno, Tavares, Juliana Carvalho, Bousbaa, Hassan

    Published in Pharmaceutics (29-12-2023)
    “…Antimitotic compounds, targeting key spindle assembly checkpoint (SAC) components (e.g., MPS1, Aurora kinase B, PLK1, KLP1, CENPE), are potential alternatives…”
    Get full text
    Journal Article
  14. 14

    Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein by Nunes, Mariana, Silva, Patrícia M A, Coelho, Ricardo, Pinto, Carla, Resende, Albina, Bousbaa, Hassan, Almeida, Gabriela M, Ricardo, Sara

    Published in Frontiers in oncology (21-10-2021)
    “…Debulking surgery followed by chemotherapy are the standard of care for high-grade serous carcinoma. After an initial good response to treatment, the majority…”
    Get full text
    Journal Article
  15. 15

    New Alkoxy Flavone Derivatives Targeting Caspases: Synthesis and Antitumor Activity Evaluation by Moreira, Joana, Ribeiro, Diana, Silva, Patrícia M A, Nazareth, Nair, Monteiro, Madalena, Palmeira, Andreia, Saraiva, Lucília, Pinto, Madalena, Bousbaa, Hassan, Cidade, Honorina

    Published in Molecules (Basel, Switzerland) (31-12-2018)
    “…The antitumor activity of natural flavonoids has been exhaustively reported. Previously it has been demonstrated that prenylation of flavonoids allows the…”
    Get full text
    Journal Article
  16. 16

    Antimicrobial protein rBPI21 -induced surface changes on Gram-negative and Gram-positive bacteria by Domingues, Marco M., PhD, Silva, Patrícia M., BSc, Franquelim, Henri G., PhD, Carvalho, Filomena A., PhD, Castanho, Miguel A.R.B., PhD, Santos, Nuno C., PhD

    Published in Nanomedicine (01-04-2014)
    “…Abstract New classes of antibiotics, such as antimicrobial peptides or proteins (AMPs), are crucial to deal with threatening bacterial diseases. rBPI21 is an…”
    Get full text
    Journal Article
  17. 17

    Tetracyclic Thioxanthene Derivatives: Studies on Fluorescence and Antitumor Activity by Durães, Fernando, Silva, Patrícia M. A., Novais, Pedro, Amorim, Isabel, Gales, Luís, Esteves, Cátia I. C., Guieu, Samuel, Bousbaa, Hassan, Pinto, Madalena, Sousa, Emília

    Published in Molecules (Basel, Switzerland) (31-05-2021)
    “…Thioxanthones are bioisosteres of the naturally occurring xanthones. They have been described for multiple activities, including antitumor. As such, the…”
    Get full text
    Journal Article
  18. 18

    Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel by Fonseca, Joana, Marques, Sandra, Silva, Patrícia M A, Brandão, Pedro, Cidade, Honorina, Pinto, Madalena M, Bousbaa, Hassan

    Published in Molecules (Basel, Switzerland) (29-07-2016)
    “…We previously reported that prenylated chalcone 2 (PC2), the O-prenyl derivative (2) of 2'-hydroxy-3,4,4',5,6'-pentamethoxychalcone (1), induced cytotoxicity…”
    Get full text
    Journal Article
  19. 19

    Glucocorticoids decrease the numbers and activation of mast cells by inducing the transactivation receptors of AGEs by Santoro, Tassia, Azevedo, Carolina T., e Silva, Patrícia M. R., Martins, Marco A., Carvalho, Vinicius F.

    Published in Journal of leukocyte biology (01-01-2019)
    “…Glucocorticoids (GCs) are potent anti‐allergic compounds that function, at least in part, by inhibiting signaling pathways in mast cells. We hypothesized that…”
    Get full text
    Journal Article
  20. 20

    A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel by França, Fábio, Silva, Patrícia M A, Soares, José X, Henriques, Ana C, Loureiro, Daniela R P, Azevedo, Carlos M G, Afonso, Carlos M M, Bousbaa, Hassan

    Published in Molecules (Basel, Switzerland) (10-12-2020)
    “…Microtubule-targeting agents (MTAs) remain a gold standard for the treatment of several cancer types. By interfering with microtubules dynamic, MTAs induce a…”
    Get full text
    Journal Article